Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma.

MLA

Cichocki, Frank, et al. “Nicotinamide Enhances Natural Killer Cell Function and Yields Remissions in Patients with Non-Hodgkin Lymphoma.” Science Translational Medicine, vol. 15, no. 705, July 2023, p. eade3341. EBSCOhost, https://doi.org/10.1126/scitranslmed.ade3341.

APA

Cichocki, F., Zhang, B., Wu, C.-Y., Chiu, E., Day, A., O’Connor, R. S., Yackoubov, D., Simantov, R., McKenna, D. H., Cao, Q., Defor, T. E., Janakiram, M., Wangen, R., Cayci, Z., Snyder, N., Kumar, A., Grzywacz, B., Hwang, J., Geffen, Y., … Bachanova, V. (2023). Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma. Science Translational Medicine, 15(705), eade3341. https://doi.org/10.1126/scitranslmed.ade3341

Chicago

Cichocki, Frank, Bin Zhang, Cheng-Ying Wu, Emily Chiu, Abderrahman Day, Roddy S O’Connor, Dima Yackoubov, et al. 2023. “Nicotinamide Enhances Natural Killer Cell Function and Yields Remissions in Patients with Non-Hodgkin Lymphoma.” Science Translational Medicine 15 (705): eade3341. doi:10.1126/scitranslmed.ade3341.